Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

PRESS RELEASE: NextFerm Technologies Obtains US Regulatory Marketing Approval for Astaferm(R) Astaxanthin Antioxidant, in Oil for Soft-Gels

09/02/2021 | 02:30pm EDT

DGAP-News: NextFerm Technologies Ltd. NextFerm Technologies Obtains US Regulatory Marketing Approval for Astaferm(R) Astaxanthin Antioxidant, in Oil for Soft-Gels 2021-09-02 / 20:29 The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

NextFerm Technologies (TASE:NXFR), a food-tech company developing ProteVin(TM), a vegan, yeast-based, non-GMO protein alternative and other innovative yeast-based nutrients, today announced receipt of regulatory marketing approval (Self-GRAS) for Astaferm(R), its innovative fermented astaxanthin antioxidant in the form of Oil for Soft-Gels, in the US.

Astaferm(R) is already sold in the US and Canada in the form of Gummies and powder by well-established Brands in North America.

NextFerm expects initial Purchase orders for the oil during 2021. NextFerm currently prepares to expand the marketing of Astaferm(R) for additional indications such as immune system support, as well as expanding into additional serving forms, such as water-dispersible powder for food and beverages.

Boaz Noy, Chief Executive Officer of NextFerm, said, 'Soft-Gels is the most popular form of consumption of Astaxanthin. This marketing approval allows NextFerm to expand its value proposition in the market, while increasing market awareness and offer fermented Astaxanthin in the form of oil with a competitive price, in addition to Astaxanthin in Gummies. we believe it will contribute to revenues growth in the coming quarters.'

About NextFerm Technologies

NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives.

NextFerm's flagship product is ProteVin(TM), a vegan, yeast-derived protein alternative with nutritional value that is similar to animal-derived protein and a neutral flavor, with no aftertastes that are typical of plant-based protein. ProteVin(TM) is designed for a variety of categories in the alternative protein market, which is estimated at USD13 billion, with an annual growth rate of 10%, including milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. NextFerm is gearing up for commercialization of the product in the US in 2022.

Another product currently being sold is Astaferm(R), an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. In July 2021, the Company received Regulatory Marketing Approval for Astaferm(R) in Canada.

The company has additional products which have been licensed to Lallemand, a global giant focused on yeast.

For more information, visit the NextFerm website at: www.nextferm.com

Legal Notice Regarding Forward-Looking Statements

This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company's control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company's operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company's current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company's operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details

Nextferm Technologies Ltd.

Yossi Ohana - Chief Financial Officer

+972 54-771-5893

yossio@nextferm.com

Investor and Media contact

Meirav Gomeh-Bauer

+972 54-476-4979

meirav@bauerg.com Company Website

https://www.nextferm.com/ News Source: News Direct

-----------------------------------------------------------------------------------------------------------------------

2021-09-02 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

-----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      NextFerm Technologies Ltd. 
              United States 
EQS News ID:  1231000 
 
End of News   DGAP News Service 
=------------ 

1231000 2021-09-02

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1231000&application_name=news

(END) Dow Jones Newswires

September 02, 2021 14:29 ET (18:29 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
LONDON BRENT OIL 0.20% 86.16 Delayed Quote.65.76%
WTI 0.16% 83.843 Delayed Quote.70.78%
Latest news "Companies"
05:59pHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts InnovAge Holding (INNV) Investors to Filing of Securities Fraud Lawsuit, Encourages Investors with Significant Losses to Contact Firm's Attorneys Now
GL
05:59pHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts InnovAge Holding (INNV) Investors to Filing of Securities Fraud Lawsuit, Encourages Investors with Significant Losses to Contact Firm's Attorneys Now
GL
05:59pTRATON : Navistar to pay $52 million to resolve Justice Department emissions probe
RE
05:58pMODERNA : U.S. administers 414.3 mln doses of COVID-19 vaccines - CDC
RE
05:57pWISETECH GLOBAL LTD (ASX : WTC) Appoints Two Independent Non-Executive Directors
AQ
05:56pREGIONAL B DE C : Download the results for the Third Quarter
PU
05:56pBENEFITFOCUS : Set to Deliver Full-Scale Open Enrollment Experience to Benefits Leaders
PU
05:56pREGIONAL B DE C : Download the Press Release for the 3Q21
PU
05:56pKLONDIKE GOLD : Closes First Tranche Raising $2,242,851
PU
05:56pGENERAL ANNOUNCEMENT : :Telstra Digicel Pacific announcement - Transcript
PU
Latest news "Companies"